Disruptive business models for competitive advantage
Regenerative medicine, particularly cell and gene therapy, is a global game changer in healthcare. The Cell and Gene Therapy sector in Wales is a rapidly emerging division within Life Sciences drawing on infrastructure and expertise from a wide variety of organisations and reflects a major opportunity for Wales on a global stage.
In order to best deliver the opportunities for all stakeholders (including academia, start-ups, SMEs, Anchor, NHS and Blood Services) there is a need to develop a robust business model that will commit to a number of key challenges in the sector.
The Challenge is how to formulate a business model thatdelivers the key objectives for the sector.